Get started
GLOBUS MEDICDRNGLOBUS MEDICDRNGLOBUS MEDICDRN

GLOBUS MEDICDRN

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

G2ME34 trade ideas

Globus Medical: Approaching resistance, is a breakthrough comingWeekly Chart ● The stock has tested the trendline resistance multiple times. ● Currently, it is trading just below this level. ● A breakout above this resistance is anticipated in the near future. ● Following the breakout, the price may increase. Daily Chart ● A Symmetrical Triangle pattern has formed. ● A strong breakout has taken place, supported by significant volume. ● The price is now set for a potential upward movement.
NYSE:GMEDLong
by NaranjCapital
Looking for a long term entry into Globus MedicalI’m looking for a long term investment in a sea of overvalued bio & tech companies. Globus Medical caught my eye as a potential candidate after a large dark pool sell and recent pullback in indexes Globus Medical's index membership is Russell 1000, Russell 3000 and S&P Midcap 400. Financial Observations: PE ratio of 37 a return to 2017 levels. 7B Market Cap Consistent Year over Year revenue growth. Nominal Debt Exceeds earnings expectations Steady asset growth Regular employment growth Personal Experience A surgical clinic I do marketing and websites for recently added one of the Globus Medical robot arm surgical assistants. The chief surgeon told me his surgery averages went from 1hr to 10m. The client has also made it a priority for us to increase marketing spend and patient intake support to increase daily surgery capacity. I’m curious to know what the more seasoned investors think of GMED and if this is a good time to make an entry for a long term holding. Not Financial Advice. Just my own Personal Investment Due Diligence.
NYSE:GMEDLong
by SPYvsGME
1
GLOBUS MEDICAL is a breakout above $50GMED recently reported inline earnings but has now come to our attention on the possibility of a substantial breakout, it has also come to light that multiple Investment and Capital management firms have made significant acquisitions of the stock. This has brought it to the attention of many and has helped and will continue to propel the stock higher in our opinion. AVERAGE ANALYSTS PRICE TARGET $53 AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT P/E RATIO 35 SHORT INTEREST 3.4% COMPANY PROFILE Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul in March 2003 and is headquartered in Audubon, PA.
NYSE:GMEDLong
by RedHotStocks
GMED where to next???With Earnings set for 02/21 GMED looks to be chopping around at the key resistance line as indicated in red. The support line short term uptrend has recently been broken, which indicates that price may push lower and chop around the current resistance point until earnings. It is probable that price action will build up for a break out and push higher, especially after earnings. Confirmation of the RSI divergence and SMII upward push will give entrance. The double bottom, looks to indicate that there is strong support to push price higher. Although the longer term looks bearish, GMED may be gearing up for a breakout! Keep an eye on price action at current resistance, with a push towards the upper resistance and a possible breakout.
NYSE:GMEDLong
by lbustos1